Virtu KCG Holdings’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Virtu KCG Holdings’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$123K	Sell	48,040 -48,604	-50%	-$132K	﹤0.01%	2360
2017 Q1	$354K	Buy	+96,644	New	+$408K	0.01%	1759
2016 Q4	–	Sell	-10,558	Closed	-$487K	–	3909
2016 Q3	$487K	Buy	10,558 +4,754	+82%	+$268K	0.01%	1403
2016 Q2	$296K	Buy	+5,804	New	+$288K	0.01%	1891
2015 Q2	–	Sell	-5,746	Closed	-$267K	–	3878
2015 Q1	$267K	Sell	5,746 -2,118	-27%	-$110K	0.01%	2041
2014 Q4	$353K	Buy	+7,864	New	+$330K	0.01%	2138

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu KCG Holdings's ISEE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its IVERIC bio, Inc. Common Stock (ISEE) stake by 50% in Q2 2017, selling an estimated $132K and leaving 48,040 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Virtu KCG Holdings first reported a position in ISEE in Q4 2014 and has held it in 6 quarters since. The position peaked at $487K in Q3 2016. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

Virtu KCG Holdings held 48,040 shares of IVERIC bio, Inc. Common Stock worth $123K as of Q2 2017.
Virtu KCG Holdings sold 48,604 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $132K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2360 holding.
Virtu KCG Holdings first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and has held it in 6 quarters since.
Virtu KCG Holdings's IVERIC bio, Inc. Common Stock position peaked at $487K in Q3 2016.
77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.